Fontana RJ - Search Results

1

Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort.

Terrault NA, Wahed AS, Feld JJ, Cooper SL, Ghany MG, Lisker-Melman M, Perrillo R, Sterling RK, Khalili M, Chung RT, Rosenthal P, Fontana RJ, Sarowar A, Lau DTY, Wang J, Lok AS, Janssen HLA. Terrault NA, et al. Among authors: fontana rj. Hepatology. 2022 Mar;75(3):709-723. doi: 10.1002/hep.32231. Epub 2022 Jan 26. Hepatology. 2022. PMID: 34743343 Free PMC article.

2

High-dose interferon alfa-2b and ribavirin in patients previously treated with interferon: results of a prospective, randomized, controlled trial.

Fontana RJ, Walsh J, Moyer CA, Lok AS, Webster S, Klein S. Fontana RJ, et al. J Clin Gastroenterol. 2002 Feb;34(2):177-82. doi: 10.1097/00004836-200202000-00015. J Clin Gastroenterol. 2002. PMID: 11782615 Clinical Trial.

3

Emotional distress in chronic hepatitis C patients not receiving antiviral therapy.

Fontana RJ, Hussain KB, Schwartz SM, Moyer CA, Su GL, Lok AS. Fontana RJ, et al. J Hepatol. 2002 Mar;36(3):401-7. doi: 10.1016/s0168-8278(01)00280-x. J Hepatol. 2002. PMID: 11867185

4

Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

Fontana RJ, Keeffe EB, Carey W, Fried M, Reddy R, Kowdley KV, Soldevila-Pico C, McClure LA, Lok AS; National Institutes of Health Hepatitis B Virus Orthotopic Liver Transplantation Study Group. Fontana RJ, et al. Liver Transpl. 2002 May;8(5):433-9. doi: 10.1053/jlts.2002.32983. Liver Transpl. 2002. PMID: 12004342 Free article.

5

Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy.

Fontana RJ, Hann HW, Perrillo RP, Vierling JM, Wright T, Rakela J, Anschuetz G, Davis R, Gardner SD, Brown NA. Fontana RJ, et al. Gastroenterology. 2002 Sep;123(3):719-27. doi: 10.1053/gast.2002.35352. Gastroenterology. 2002. PMID: 12198698

6

Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.

Fontana RJ, Schwartz SM, Gebremariam A, Lok AS, Moyer CA. Fontana RJ, et al. Psychosomatics. 2002 Sep-Oct;43(5):378-85. doi: 10.1176/appi.psy.43.5.378. Psychosomatics. 2002. PMID: 12297606

7

Noninvasive monitoring of patients with chronic hepatitis C.

Fontana RJ, Lok AS. Fontana RJ, et al. Hepatology. 2002 Nov;36(5 Suppl 1):S57-64. doi: 10.1053/jhep.2002.36800. Hepatology. 2002. PMID: 12407577 Free article. Review.

8

Combination of HBIG and lamivudine-resistant mutations: a formula for trouble?

Fontana RJ, Lok AS. Fontana RJ, et al. Liver Transpl. 2002 Nov;8(11):1082-4. doi: 10.1053/jlts.2002.36238. Liver Transpl. 2002. PMID: 12424727 Free article. No abstract available.

9

NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States.

Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS. Marrero JA, et al. Among authors: fontana rj. Hepatology. 2002 Dec;36(6):1349-54. doi: 10.1053/jhep.2002.36939. Hepatology. 2002. PMID: 12447858 Free article.

10

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS. Marrero JA, et al. Among authors: fontana rj. Hepatology. 2003 May;37(5):1114-21. doi: 10.1053/jhep.2003.50195. Hepatology. 2003. PMID: 12717392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page